ALLMedicine™ Drooling Center

Aug 4th, 2021 - This prospective phase III study (SIPEXI) investigated efficacy and safety of repeated injections of incobotulinumtoxinA (incoBoNT/A) for treatment of chronic sialorrhea (drooling) associated with neurological disorders (e.g., cerebral palsy, trau...

Jul 15th, 2021 - We compared pathogen detection between saliva, nasopharyngeal and oropharyngeal swabs in children with respiratory symptoms. The sensitivity in nasopharyngeal swabs was 93% (95% confidence interval [CI]: 78%-98%), in oropharyngeal swabs 79% (95% C...

Jun 16th, 2021 - Parkinson's disease (PD) has a negative effect on oral health and orofacial function, but the subjective experience of orofacial symptoms and their impact on the quality of life is not fully investigated. In addition, knowledge of how to improve t...

Jun 8th, 2021 - Acute epiglottitis is an airway emergency presenting with edema and inflammation of the epiglottis and aryepiglottic folds [1]. Infectious and other non-infectious etiologies may cause significant airway injury presenting with similar clinical sym...

May 5th, 2021 - We have followed the clinical course of a 45-year-old man with a severe form of alpha-thalassemia X-linked intellectual disability syndrome for 40 years. The most challenging health issue is the combination of rumination, drooling, and vomiting. T...

Oct 29th, 2018 - The objective of this study is to investigate the efficacy and safety of NT 201 compared with placebo for the treatment of chronic troublesome sialorrhea associated with neurological disorders (e.g. cerebral palsy, traumatic brain injury) and/or i...

Jun 1st, 2018 - This study will evaluate the efficacy and safety of MYOBLOC in the treatment of Sialorrhea (drooling), which can be a symptom of many disease conditions. MYOBLOC will be injected directly into the salivary glands. MYOBLOC has been shown in previou...

Oct 27th, 2017 - The facial paralysis is a frequent disease causing important functionals swallowing dysfunctions. The purpose of our study was to evaluate the improvement of the swallowing disorders after surgery by lengthening temporalis myoplasty (LTM) in the f...

Apr 23rd, 2015 - Study Objectives: To determine the efficacy, safety, tolerability and adverse effects of three doses of Dysport® (50MU, 100MU and 200MU) in the treatment of sialorrhoea in Asian patients with neurological disorders/diseases and to determine the mo...

Jan 8th, 2015 - Title To formulate and see efficacy of passive oral motor regimen for drooling in children with multiple disabilities Background Drooling ranges from mild embarrassment and discomfort for the intellectually intact patient with minimal drooling to ...

Jun 24th, 2021 - Excessive drooling by patients with advanced Parkinson's disease is an indicator of greater motor and nonmotor dysfunction, new research shows. "Sialorrhea is not just a cosmetic problem," study investigator Francesca Morgante, MD, associate profe...

Feb 10th, 2020 - Question 1 of 2 Which of the following signs or symptoms is more commonly associated with an impacted esophageal foreign body? Your Peers Chose: Absence of drool 0% Chest pain 0% Diarrhea 0% Lower abdominal pain 0% When present, symptoms of esopha...

Sep 3rd, 2019 - An 83-year-old woman with hypertension, hypothyroidism, and a history of depression presented to the emergency department with acute shortness of breath and hypoxia. She was found to have submassive pulmonary embolism, and a heparin infusion was s.

May 13th, 2019 - PHILADELPHIA — The US Food and Drug Administration (FDA) has approved broadening the indication for incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals) as first-line therapy for blepharospasm in adult patients, the manufacturer has announced. Benig...

Apr 8th, 2019 - IncobotulinumtoxinA (Xeomin, Merz Pharmaceutials) injected into the salivary glands provides lasting improvement in chronic sialorrhea (excessive drooling), new research shows. Results of the Sialorrhea in Adults Xeomin Investigation (SIAXI) study...